With the rising incidence of cancer in India, AstraZeneca India's breast cancer medicine trastuzumab deruxtecan (sold under the brand name Enhertu) emerged as the highest-selling new drug brand ...

Shares of Vodafone Idea (Vi) dropped nearly 2 percent and are currently trading at around Rs 8.94 per share. The company is ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

Among individual stocks, Vodafone Idea, Berger Paints, Lupin, AstraZeneca Pharma, and Birlasoft will be in focus as they are ...

When drug companies manipulate the system to increase profits, patients suffer. Arizona Attorney General Kris Mayes is right to take GlaxoSmithKline to court over its decision to discontinue Flovent, ...

Shares of firms like Vodafone Idea, Nykaa, Hindalco, Patanjali Foods, GAIL, and others will be in focus on Tuesday's trade ...

Policy Exchange attacks repeal of parts of Tories' Legacy Act, which removes a block on people like Gerry Adams seeking ...

The cost of dealing with Northern Ireland’s troubled past is set to be considerably more than £2 billion, a UK think tank has ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

A coroner overseeing the inquest of a woman who died following a Covid vaccine has stood down amid claims of bias and ...

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

Goldman Sachs updated its price target on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN) shares to GBP150.67, down from GBP155.58, while reaffirming a Buy rating on the stock. The adjustment follows a ...